Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women
Sunday, November 7, 2010 - 00:24
in Health & Medicine
Lasofoxifene statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density, according to a new study.